BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, July 25, 2026
Home » Topics » Medical technology, Financings

Medical technology, Financings
Medical technology, Financings RSS Feed RSS

Financings for Oct. 29, 2020

Oct. 29, 2020
Med-tech firms raising money in public or private financings, including: Advanced Chemotherapy Technologies, Baxter International, Relievant Medsystems.
Read More
European Union flag, coins

European Commission providing $180M for public-private partnership investments in health care startups

Oct. 28, 2020
By Bernard Banga
PARIS – At the recent annual HealthTech Innovations Days in Paris, the European investment Fund (EIF) and the world’s largest life sciences consortium, EIT Health Germany, reported the development of a Venture Centre of Excellence (VCoE) in Europe.
Read More

Financings for Oct. 28, 2020

Oct. 28, 2020
Med-tech firms raising money in public or private financings, including: Biodesix , K?lahealth, Sidekick Health.
Read More

Financings for Oct. 27, 2020

Oct. 27, 2020
Med-tech firms raising money in public or private financings, including: Abm Respiratory Care, Caris Life Sciences, Eucrates Biomedical, Helius Medical Technologies, Intuitive Surgical.
Read More

Financings for Oct. 26, 2020

Oct. 26, 2020
Med-tech firms raising money in public or private financings, including: Goodcell, Lux Health Tech.
Read More
Device image

EU takes stake in Carthera to boost development of ultrasound-based technology for treating brain cancer

Oct. 26, 2020
By Bernard Banga
PARIS – Carthera SAS, of Paris, has obtained a $2.4 million grant and $12.5 million equity investment from the European Innovation Council (EIC) for the development of its ultrasound-based medical device for treating glioblastoma.
Read More

Financings for Oct. 23, 2020

Oct. 23, 2020
Med-tech firms raising money in public or private financings, including: Eucrates Biomedical Acquisition, Vapotherm, Xtant Medical Holdings.
Read More
10-22-Lenire-Device-hero

Neuromod scoops up €10.5M in series B funding

Oct. 22, 2020
By Meg Bryant
Neuromod Devices Ltd., which is developing an at-home, self-managed treatment for tinnitus, closed a €10.5 million (US$12.4 million) series B financing led by majority investor Fountain Healthcare Partners. The funds are earmarked for expanding European commercialization of the Lenire tinnitus treatment device, to scale up manufacturing, progress U.S. FDA regulatory approval and pursue opportunities with the U.S. Department of Veterans Affairs (VA).
Read More

Financings for Oct. 22, 2020

Oct. 22, 2020
Med-tech firms raising money in public or private financings, including: Cricket Health, Enviral Tech, Helius Medical Technologies, Invivo Therapeutics Holdings, Neodynamics.
Read More

Financings for Oct. 21, 2020

Oct. 21, 2020
Med-tech firms raising money in public or private financings, including: Astrotech, Eargo, Loyal, Phreesia.
Read More
Previous 1 2 … 208 209 210 211 212 213 214 215 216 … 259 260 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 24, 2026.
  • Red CAR T cell on blue blackground

    To viral or not to viral: In vivo CAR T debates delivery tech

    BioWorld
    The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 21, 2026
  • Red CAR T cell on blue blackground

    To viral or not to viral: In vivo CAR T debates delivery tech

    BioWorld Science
    The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
  • Red CAR T cell on blue blackground

    To viral or not to viral: In vivo CAR T debates delivery tech

    BioWorld Asia
    The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
    • Videos
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing